Delve into a detailed analysis of colorectal cancer epidemiology, examining incidence rates, emerging trends, and the broader impact on global health. Gain valuable insights into the prevalence and distribution of this disease, informing strategies for prevention, early detection, and improved patient outcomes. Stay informed with the latest epidemiological data to shape effective healthcare policies and interventions.

For more insights on colorectal cancer market forecast data, download a free report sample

The total number of cases affected by colorectal cancer was 3,183,569 in 2021. The number of cases is expected to grow at an AGR of more than 3% during the forecast period. Colorectal cancer, also referred as bowel cancer, is the cancer of the colon, rectum, or rectosigmoid junction. It is a type of gastrointestinal malignancy originating from either the colon or the rectum. Although both forms can be defined as colon or rectal cancers, depending on their origin, they are often merged because of the many biologically and clinically common features (American Cancer Society, 2020a). CRC is the second most lethal cancer after lung cancer, and the third most diagnosed malignant tumor worldwide.

The Colorectal Cancer Epidemiology Analysis and Forecast market research report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for CRC in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China). The report includes a 10-year epidemiology forecast for the diagnosed incident cases of CRC. The diagnosed incident cases of CRC are segmented by age (18–29 years, 30–39 years, 40–49 years, 50–59 years, 60–69 years, 70–79 years, and 80 years and older) and sex.